Disease Activity In Systemic Lupus Erythematosus Patients Not Increased By The HPV Vaccine Gardasil
5/27/2011
Results of a Chinese study showed that the HPV vaccine did not have significant effects on the number of disease flares or antibody measures in patients with inactive SLE receiving stable doses of medications after administration, and therefore was determined safe to use to prevent HPV in this group of patients...
How Drug For Leukemia, Psoriasis, May Tackle Vascular Disease
5/27/2011
A drug that has been on the market for decades to treat leukemia and skin disorders such as acne and psoriasis may be a possible therapy for vascular diseases, including atherosclerosis and hypertension, which can lead to heart attack or stroke...
Breast Cancer Growth Inhibited By Common Transplant Drug
5/27/2011
Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th PLoS ONE...
Prolonging Life Carries More Weight Than Enhancing Life For Oncologists
5/27/2011
Doctors are more apt to recommend a more costly therapy to patients if it were determined to prolong the patient's life rather than just improve quality, according to a recent study from Medical Decision Making (published by SAGE)...
A new prostate cancer study published in the New England Journal of Medicine comparing surgical treatment to "watchful waiting" revealed important findings for patients newly diagnosed with prostate cancer and currently debating their treatment options...
OncoSec Medical To Initiate Multiple Phase II Skin Cancer Clinical Trials
5/27/2011
OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced it will initiate three Phase II clinical trials to assess its cancer-destroying, tissue-sparing ElectroImmunotherapy technology in patients with melanoma, Merkel cell carcinoma and cutaneous T-cell lymphoma...
Northwest Biotherapeutics Further Expands Ongoing Brain Cancer Trial
5/27/2011
Northwest Biotherapeutics (OTC.BB: NWBO) announced that it has accelerated the addition of clinical trial sites, exceeding its projections for the doubling of such sites across the U.S...
Tigris Pharmaceuticals, Inc., announced enrollment of its first patient in a randomized Phase 2 clinical trial of AFP-464 (aminoflavone prodrug) with or without Faslodex® (fulvestrant) in estrogen receptor (ER)-positive breast cancer patients...
EMIT Corporation Receives FDA 510(k) Clearance For HypothermX™ Blood And Fluid Warmer
5/27/2011
EMIT Corporation announced that it has received U.S. Food and Drug Administration 510(k) clearance to market the HypothermX™ HX100 device...
New Prostate Cancer Treatments Today: Zytiga And The Yunzi Mushroom?
5/26/2011
This week two developments in prostate cancer have been unveiled. First, Zytiga (abiraterone acetate), an ingested pill treatment, has been found to potentially extend life by up to four months in men with spreading cancer who have already been treated with chemotherapy...